Arash Rezazadeh Kalebasty has Hematology/oncology as his primary medical specialty. Their primary office is: 101 The City Dr S in Orange, California.
They're a part of the: Uc Regents medical group which has around 213 members. You can call their office at 714-456-7004 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 1989 (around 35 years of experience). They are listed as doing telehealth appointments.
Arash Rezazadeh Kalebasty
Uc Regents
101 The City Dr S
Orange, California 92868
714-456-7004
Phone: 714-456-7004
Enter a starting address:
Medical School: Sorry, his university is not listed
Graduation Year: 1989
The Primary Medical Specialty for Arash Rezazadeh Kalebasty is listed as: Hematology/oncology
Approximate Years of Experience: 35
PAC (PECOS ID)#: 9830283373
NPI #: 1205974755
NPI Created On: 02/04/2007
NPI Last Updated Listed as: 04/14/2023
Primary Taxonomy Code: 207RH0003X
License Number:
40927
Listed Gender: Male
Forms of insurance accepted by include, but are not limited to:
They are listed as accepting new patients.
Languages spoken by staff include: English, Spanish.
Services and Procedures include:
Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.
Payments Total: $1,925
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Third party is a Charity:: No
Record ID:: 787613333
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: ERLEADA
Open Associated Drug #1: 59676-600-12
Payments Total: $550
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Third party is a Charity:: No
Record ID:: 787992511
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: ERLEADA
Open Associated Drug #1: 59676-600-12
Payments Total: $550
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Third party is a Charity:: No
Record ID:: 787992513
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: BALVERSA
Open Associated Drug #1: 59676-030-56
Payments Total: $1,100
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Third party is a Charity:: No
Record ID:: 787992515
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: BALVERSA
Open Associated Drug #1: 59676-030-56
Payments Total: $1,650
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Record ID:: 783506443
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: Oncology
Name of Drug #1: OPDIVO
Open Associated Drug #1: 0003-3774-12
Payments Total: $1,650
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Record ID:: 783506453
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: Oncology
Name of Drug #1: OPDIVO
Open Associated Drug #1: 0003-3774-12
Payments Total: $1,650
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Record ID:: 783506461
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: Oncology
Name of Drug #1: OPDIVO
Open Associated Drug #1: 0003-3774-12
Payments Total: $1,650
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Record ID:: 783506489
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: Oncology
Name of Drug #1: OPDIVO
Open Associated Drug #1: 0003-3774-12
Payments Total: $1,650
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Record ID:: 783506491
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: Oncology
Name of Drug #1: OPDIVO
Open Associated Drug #1: 0003-3774-12
Payments Total: $1,650
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Record ID:: 783506503
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: Oncology
Name of Drug #1: OPDIVO
Open Associated Drug #1: 0003-3774-12
101 The City Dr S
Orange, CA
Uc Regents
1010 W La Veta Ave
Orange, CA
Providence Medical Foundation
101 The City S Dr
Orange, CA
Uc Regents
1010 W La Veta Ave
Orange, CA
Providence Medical Foundation
101 The City Dr S
Orange, CA
Uc Regents
101 The City Dr S
Orange, CA
Uc Regents
101 The City Dr S
Orange Ca 92868-3201
Uc Regents
Nurse Practitioner
101 The City Dr S
Orange Ca 92868-3201
Uc Regents
Nephrology
101 The City S Dr
Orange Ca 92868-3201
Uc Regents
Physician Assistant
101 The City Dr S
Orange Ca 92868-3201
Uc Regents
Physician Assistant
101 The City Dr S
Orange Ca 92868-3201
Uc Regents
Physician Assistant
101 The City S Dr
Orange Ca 92868-3201
Uc Regents
Nephrology
View all 213 members of Uc Regents medical group